These results, along with a past report demonstrating that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 assist the notion of concentrating on ACKR3 as a novel strategy to modulate the opioid technique, which could open up new therapeutic avenues for opioid-related disorders.A different study reveals which the com